Certified by Founder Lodge
ImmuneBridge
United States - San Francisco, California
START UP
1 Disclosed Funding Rounds $12,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consisten
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 13 ,2023 | Seed | $12,000,000 |
M Ventures
One Way Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Opti | $20,000,000 | (Nov 25, 2025)
Interface | $3,500,000 | (Nov 25, 2025)
Cordance Medical | $8,000,000 | (Nov 25, 2025)
AI One | $7,000,000 | (Nov 25, 2025)
Votre | $3,750,000 | (Nov 25, 2025)
